Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer
Go back to Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 212.50 -8.33 (3.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $220.83 | 52 Week High | $333.65 | |||
| Open | $215.45 | 52 Week Low | $223.02 | |||
| Day High | $217.28 | P/E | 27.21 | |||
| Day Low | $210.54 | EPS | $7.81 | |||
| Volume | 617,826 | |||||
| (NASDAQ: STOK) | Delayed: 30.05 +0.24 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.81 | 52 Week High | $ | |||
| Open | $29.13 | 52 Week Low | $ | |||
| Day High | $30.68 | P/E | N/A | |||
| Day Low | $28.89 | EPS | $ | |||
| Volume | 680,965 | |||||
